N. Harris, E. Jaffe, H. Stein, P. Banks, J. Chan et al., A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma study group, Current Diagnostic Pathology, vol.2, issue.1, pp.1361-92, 1994.
DOI : 10.1016/S0968-6053(00)80051-4

N. Harris, Hodgkin's lymphomas: classification, diagnosis, and grading, Semin Hematol, vol.36, pp.220-252, 1999.

V. Diehl, J. Franklin, M. Sextro, P. Mauch, P. Mauch et al., Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease

V. Diehl, M. Sextro, J. Fanklin, M. Hansmann, N. Harris et al., Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease, Journal of Clinical Oncology, vol.17, issue.3, pp.776-90, 1999.
DOI : 10.1200/JCO.1999.17.3.776

E. Orlandi, M. Lazzarino, M. Brusamolino, M. Paulli, C. Astori et al., Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence, Leukemia & Lymphoma, vol.7, issue.15, pp.359-68, 1997.
DOI : 10.1007/BF01611185

R. Wilder, P. Schlembach, D. Jones, G. Chronowski, C. Ha et al., European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease, Cancer, vol.96, issue.6, pp.1731-1739, 2002.
DOI : 10.1002/cncr.10404

P. Schlembach, R. Wilder, D. Jones, C. Ha, L. Fayad et al., Radiotherapy Alone for Lymphocyte-Predominant Hodgkin??s Disease, The Cancer Journal, vol.8, issue.5, pp.377-83, 2002.
DOI : 10.1097/00130404-200209000-00008

B. Ekstrand, J. Lucas, S. Horwitz, Z. Fan, S. Breslin et al., Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial, Blood, vol.101, issue.11, pp.4285-4294, 2003.
DOI : 10.1182/blood-2002-08-2644

B. Pellegrino, M. Terrier-lacombe, O. Oberlin, T. Leblanc, Y. Perel et al., Lymphocyte-Predominant Hodgkin???s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection???A Study of the French Society of Pediatric Oncology, Journal of Clinical Oncology, vol.21, issue.15, pp.2948-52, 2003.
DOI : 10.1200/JCO.2003.01.079

M. Juweid, G. Wiseman, J. Vose, J. Ritchie, Y. Menda et al., Response Assessment of Aggressive Non-Hodgkin???s Lymphoma by Integrated International Workshop Criteria and Fluorine-18???Fluorodeoxyglucose Positron Emission Tomography, Journal of Clinical Oncology, vol.23, issue.21, pp.4652-61, 2005.
DOI : 10.1200/JCO.2005.01.891

M. Juweid, S. Stroobants, O. Hoekstra, F. Mottaghy, M. Dietlein et al., Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.571-579, 2007.
DOI : 10.1200/JCO.2006.08.2305

B. Cheson, S. Horning, B. Coiffier, M. Shipp, R. Fisher et al., Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, Journal of Clinical Oncology, vol.17, issue.4, p.1244, 1999.
DOI : 10.1200/JCO.1999.17.4.1244

G. Jerusalem, Y. Beguin, M. Fassotte, F. Najjar, P. Paulus et al., Whole body positron emission tomography using 18F-fluoro- deoxyglucose compared to standard procedures for staging patients with Hodgkin's disease, Haematologica, vol.86, pp.266-73, 2001.

M. Hutchings, A. Loft, M. Hansen, L. Pedersen, A. Berthelsen et al., Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma, Haematologica, vol.91, pp.482-491, 2006.

G. Jerusalem, Y. Beguin, F. Najjar, R. Hustinx, M. Fassotte et al., Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of lowgrade non-Hodgkin's lymphoma (NHL), Annals of Oncology, vol.12, issue.6, pp.825-855, 2001.
DOI : 10.1023/A:1011169332265

R. Elstrom, L. Guan, G. Baker, K. Nakhoda, J. Vergilio et al., Utility of FDG-PET scanning in lymphoma by WHO classification, Blood, vol.101, issue.10, pp.3875-76, 2003.
DOI : 10.1182/blood-2002-09-2778

M. Hutchings, A. Loft, M. Hansen, E. Ralfkiaer, and L. Specht, Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake, Hematological Oncology, vol.34, issue.3, pp.146-50, 2006.
DOI : 10.1002/hon.782

H. Schoder, A. Noy, M. Gonen, L. Weng, D. Green et al., Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin???s Lymphoma, Journal of Clinical Oncology, vol.23, issue.21, pp.4643-51, 2005.
DOI : 10.1200/JCO.2005.12.072

C. Menzel, N. Dobert, P. Mitrou, M. S. Diehl, M. Berner et al., Positron Emission Tomography for the Staging of Hodgkin's Lymphoma - Increasing the Body of Evidence in Favor of the Method, Acta Oncologica, vol.41, issue.5, pp.430-436, 2002.
DOI : 10.1080/028418602320405014